The Oklahoma Sooners' last-minute victory over Texas gave former head coach Bob Stoops the perfect opportunity to call out the doubters.

Citadel founder Ken Griffin signaled his attention in US presidential debates remained on Nikki Haley, putting his hopes

Elon Musk's social media platform X has stripped headlines from news articles shared by users, in a move likely to further...

Allegations that Bola Tinubu's diplomas were fake went viral after the release of his school documents.

The average rate on the benchmark 30-year home loan fell for the second week in a row, positive news for prospective homebuyers after rates touched a 22-year high just last month

JERUSALEM Israel's jobless rate surged to near 10% in October, the Central Bureau of Statistics said on Monday,

The Republic of Ireland’s behind-closed-doors match against Colombia ahead of the Women’s World Cup was abandoned after 20 minutes after becoming “overly physical”. The PA news agency understands the decision was made following some rough challenges in Friday’s contest at Brisbane’s Meakin Park, and that Ireland midfielder Denise O’Sullivan was taken to hospital and is set to undergo a scan after sustaining a shin injury. A statement from the Football Association of Ireland said: “The behind-closed-doors game between the Ireland women’s national team and Colombia on Friday evening was ended after 20 minutes of play. “The game, which was held in Meakin Park, Brisbane, became overly physical and it was decided, following consultation with the match officials, to end the game. “The Ireland team then underwent a full training session to continue preparations for their opening game in FIFA Women’s World Cup 2023, against Australia in Sydney on July 20.” Vera Pauw’s Ireland team are also set to face Canada in Perth on July 26 and then Nigeria in Brisbane five days later, as the Girls in Green play at a major tournament finals for the first time in their history. Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live

A treatment for acute migraines has been approved for NHS use for the first time, with experts saying the move could be a “step-change” for thousands of people who suffer from the condition. The National Institute for Health and Care Excellence (Nice) said its final draft guidance on Rimegepant “addresses the high unmet need for treatment options for acute migraine”. Rimegepant, also known as Vydura and made by Pfizer, will be available to adults who have tried at least two triptans – medication usually given to tackle headaches or migraines – but found they did not work well enough. It can also be administered to those who are not able to take triptans or have an intolerance, or patients who have tried nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol. Helen Knight, director of medicines evaluation at Nice, said: “Migraine is a condition described in comments to Nice from carers and people with migraine as an invisible disability that affects all aspects of life including work, education, finances, mental health, social activities and family. “Today’s final draft guidance addresses the high unmet need for treatment options for acute migraine, once again demonstrating our ability to ensure clinically and cost-effective medicines are available to those who need them as quickly as possible.” Rimegepant is taken as a wafer, which dissolves under the tongue and works by stopping the release of a protein around the brain called calcitonin gene-related peptide. In July, the medicine was recommended as an option for preventing episodic migraines in adults who have at least four and fewer than 15 attacks per month if “at least” three other treatments have not worked. This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment Helen Knight, Nice Under the latest guidance, it will also be used to relieve symptoms of a migraine, which can include pain, nausea and sensitivity to light, but also painless symptoms such as temporary visual disturbances known as “aura”, which Nice said “is not well managed with existing treatments”. The recommendation is expected to benefit about 13,000 people. Ms Knight added: “This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment.” Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health Robert Music, The Migraine Trust Robert Music, chief executive of The Migraine Trust, said the Nice guidance “provides people with migraine valuable options to help reduce the pain and length of a migraine attack”. “It brings new hope,” he added. “It will especially benefit those who have not found a treatment that works, those who get debilitating side effects – including medicine overuse headache – from them, and those with cardiovascular disease who cannot take existing treatments. “Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health.” Read More NHS winter resilience fund announced by Government NHS reliance on paper notes ‘stopping trusts from realising full potential’ Recession fears as UK economy shrinks by more than expected in shock decline Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live

China's ruling Communist Party is calling for beefed-up national security measures, highlighting risks from artificial intelligence

According to a report, in March of this year, Natalie Portman discovered that her husband was having 'an affair with a young woman'

Richer Americans are curtailing their spending ahead of Black Friday, a worrisome sign for an economy that has

Country singer Morgan Wallen’s “Last Night” tops Apple Music’s global song chart in 2023